CROI 2017 Program and Information

Program and Agenda

Oral Abstract O-7 TB AND OTHER OPPORTUNISTIC INFECTIONS Room 6 C Oral Abstract Moderators Haileyesus Getahun , World Health Organization, Geneva, Switzerland Richard Hafner, NIAID, NIH, Bethesda, MD, USA 76LB AMULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS Clinical Diagnostics Research Consortium and FIND Trial Consortium 1 FIND, Geneva, Switzerland, 2 Boston Med Cntr, Boston, MA, USA, 3 Univ of Med and Dentistry of New Jersey, Newark, NJ, USA, 4 The Johns Hopkins Univ, Baltimore, MD, USA 77 WHOLE-GENOME SEQUENCING AND SPATIAL ANALYSIS OF XDR TB TRANSMISSION IN SOUTH AFRICA Kristin N. Nelson 1 , Neel R. Gandhi 1 , Sara C. Auld 1 , James C. Brust 2 , Barun Mathema 3 , Nazir Ismail 4 , Pravi Moodley 5 , Angela Campbell 1 , Salim Allana 1 , N. Sarita Shah 6 1 Emory Univ, Atlanta, GA, USA, 2 Albert Einstein Coll of Med, Bronx, NY, USA, 3 Columbia Univ, New York, NY, USA, 4 NICD, Johannesburg, South Africa, 5 Univ of KwaZulu-Natal, Durban, South Africa, 6 CDC, Atlanta, GA, USA 78 SIX-MONTH IPT REDUCESMORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTSWITHHIGH CD4 10:00 10:15 10:30 10:00 AM - 12:00 PM Samuel G. Schumacher 1 , Pamela Nabeta 1 , Catharina C. Boehme 1 , Jerrold Ellner 2 , David Alland 3 , Susan E. Dorman 4 , Claudia M. Denkinger 1 , for the TB Anani D. Badje 1 , Raoul Moh 2 , Delphine Gabillard 1 , Calixte Guehi 3 , Mathieu Kabran 2 , Hervé Menan 2 , André Inwoley 2 , Christine Danel 1 , Serge Eholie 4 , Xavier Anglaret 1 1 INSERM, Bordeaux, France, 2 Prog PAC-CI, ANRS Rsr site, Abidjan, Cote d’Ivoire, 3 INSERM, Abidjan, Cote d’Ivoire, 4 Service des Maladies Infectieuses et Tropes, Abidjan, Cote d’Ivoire 79 THE ESSENTIALITY OF INH DURING THE FIRST 14 DAYS OF TB THERAPY: THE A5307 EBA TRIAL Andreas H. Diacon 1 , Sachiko Miyahara 2 , Xin Sun 2 , Richard Hafner 3 , Florian von Groote-Bidlingmaier 4 , Courtney Fletcher 5 , Evelyn Hogg 6 , Rodney Dawson 7 , Susan Swindells 5 , William Bishai 8 1 Stellenbosch Univ, Cape Town, South Africa, 2 Harvard Univ, Boston, MA, USA, 3 NIH, Bethesda, MD, USA, 4 TASK Applied Sci, Cape Town, South Africa, 5 Univ of Nebraska Med Cntr, Omaha, NE, USA, 6 Social &Scientific Systems, Silver Spring, MD, USA, 7 Univ of Cape Town, Mowbray, South Africa, 8 The Johns Hopkins Univ, Baltimore, MD, USA 80LB THE NIX-TB TRIAL OF PRETOMANID, BEDAQUILINE AND LINEZOLID TO TREAT XDR-TB Francesca Conradie 1 , Andreas H. Diacon 2 , Daniel Everitt 3 , Carl Mendel 3 , Christo van Niekerk 4 , Pauline Howell 5 , Kyla Comins 6 , Mel Spigelman 3 1 Univ of the WItswatersrand, Johannesburg, SA, 2 Stellenbosch Univ, Cape Town, SA, 3 Global Alliance for TB Drug Development, New York, NY, USA, 4 Global Alliance for TB Drug Development, Pretoria, SA, 5 Clinical HIV Rsr Unit, Johannesburg, SA, 6 TASK Applied Science, Belville, SA 81LB RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS Graeme Meintjes 1 , Cari Stek 2 , Liz Blumenthal 1 , Friedrich Thienemann 1 , Charlotte Schutz 1 , Jozefien Buyze 2 , Gary Maartens 1 , Robert Wilkinson 3 , Lutgarde Lynen 2 , for the PredART Trial Team 1 Univ of Cape Town, Cape Town, South Africa, 2 Inst of Tropical Med, Antwerp, Belgium, 3 Imperial Coll, London, UK 10:45 11:00

Oral Sessions • Wednesday 11:15

CROI 2017 48